Ryo Fujiwara

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Metastatic Renal Cell Carcinoma

Clinical Practice

Prognostic Factors

Lymph Node Metastasis

Top Venues

Expert review of anticancer therapy

International journal of urology : official journal of the Japanese Urological Association

IJU case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Zarba, Ryo Fujiwara, Takeshi Yuasa, Fumitaka Koga, Daniel Y C Heng, Kosuke Takemura
Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review. Expert review of anticancer therapy (2024)
Yosuke Yasuda, Noboru Numao, Ryo Fujiwara, Kosuke Takemura, Yusuke Yoneoka, Tomohiko Oguchi, Shinya Yamamoto, Junji Yonese
Surgical outcomes and predictive value for major complications of robot-assisted radical cystectomy of real-world data in a single institution in Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Martin Zarba, Ryo Fujiwara, Takeshi Yuasa, Fumitaka Koga, Daniel Y C Heng, Kosuke Takemura
Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review. Expert review of anticancer therapy (2024)
Ryo Fujiwara, Shinya Yamamoto, Kosuke Takemura, Takeshi Yuasa, Noboru Numao, Tomohiko Oguchi, Yosuke Yasuda, Yusuke Yoneoka, Junji Yonese
Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy. Cancers 16 (15) (2024)
Yosuke Yasuda, Noboru Numao, Ryo Fujiwara, Kosuke Takemura, Yusuke Yoneoka, Tomohiko Oguchi, Shinya Yamamoto, Junji Yonese
Surgical outcomes and predictive value for major complications of robot-assisted radical cystectomy of real-world data in a single institution in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (7) (2024)
Martin Zarba, Ryo Fujiwara, Takeshi Yuasa, Fumitaka Koga, Daniel Y C Heng, Kosuke Takemura
Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review. Expert review of anticancer therapy 24 (8) (2024)
Ryo Fujiwara, Shinya Yamamoto, Kosuke Takemura, Takeshi Yuasa, Noboru Numao, Tomohiko Oguchi, Yosuke Yasuda, Yusuke Yoneoka, Junji Yonese
Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy. Cancers 16 (15) (2024)
Ryo Fujiwara, Takeshi Yuasa, Kenichi Kobayashi, Tetsuya Yoshida, Susumu Kageyama
Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese population. Expert review of anticancer therapy (2023)
Ichiro Yonese, Noboru Numao, Kentaro Inamura, Yusuke Yoneoka, Ryo Fujiwara, Yosuke Yasuda, Tomohiko Oguchi, Shinya Yamamoto, Takeshi Yuasa, Junji Yonese
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy. IJU case reports 7 (1) (2023)
Ichiro Yonese, Noboru Numao, Kentaro Inamura, Yusuke Yoneoka, Ryo Fujiwara, Yosuke Yasuda, Tomohiko Oguchi, Shinya Yamamoto, Takeshi Yuasa, Junji Yonese
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy. IJU case reports 7 (1) (2023)
Minami Une, Ryo Fujiwara, Arisa Ueki, Ryosuke Oki, Tetsuya Urasaki, Kentaro Inamura, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
A case of sequential medical therapy for advanced ureteral cancer in Li-Fraumeni syndrome. IJU case reports 6 (5) (2023)
Kosuke Hamada, Yoshinobu Komai, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Junji Yonese
Doppler ultrasonography as a screening test for the detection of asymptomatic renal artery pseudoaneurysms following partial nephrectomy: A 15-year single-institution experience. International journal of urology : official journal of the Japanese Urological Association (2023)
Minami Une, Ryo Fujiwara, Arisa Ueki, Ryosuke Oki, Tetsuya Urasaki, Kentaro Inamura, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
A case of sequential medical therapy for advanced ureteral cancer in Li-Fraumeni syndrome. IJU case reports 6 (5) (2023)
Motohiro Fujiwara, Noboru Numao, Shinya Yamamoto, Yudai Ishikawa, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Yoh Matsuoka, Takeshi Yuasa, Junji Yonese
Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side-specific negative lymph node metastasis at radical prostatectomy. The Prostate 82 (8) (2022)
Kosuke Hamada, Ryo Fujiwara, Kosuke Takemura, Yoshinobu Komai, Tomohiko Oguchi, Noboru Numao, Shinya Yamamoto, Junji Yonese, Takeshi Yuasa
Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 29 (10) (2022)
Ryo Fujiwara, Susumu Kageyama, Takeshi Yuasa
Developments in personalized therapy for metastatic renal cell carcinoma. Expert review of anticancer therapy 22 (6) (2022)
Ryo Fujiwara, Takeshi Yuasa, Shinya Yamamoto, Motohiro Fujiwara, Kosuke Takemura, Tetsuya Urasaki, Ryosuke Oki, Yoshinobu Komai, Tomohiko Oguchi, Noboru Numao, Junji Yonese
Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab. Nutrition and cancer (2022)
Motohiro Fujiwara, Takeshi Yuasa, Tetsuya Urasaki, Yoshinobu Komai, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Junji Yonese
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan. Cancer reports (Hoboken, N.J.) (2021)
Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese
First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. International journal of urology : official journal of the Japanese Urological Association 28 (9) (2021)
Ryo Fujiwara, Kentaro Inamura, Takeshi Yuasa, Noboru Numao, Shinya Yamamoto, Hitoshi Masuda, Akihiro Kawauchi, Kengo Takeuchi, Junji Yonese
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer. International journal of clinical oncology 25 (1) (2019)